Moneycontrol
HomeNewsBusinessDr Angelique Coetzee who first spotted Omicron: We’re not going to get out of this easily

Dr Angelique Coetzee who first spotted Omicron: We’re not going to get out of this easily

The South African doctor talks to Moneycontrol about how she detected Omicron, new variants and using commonsense, and not Facebook or Twitter in times of a pandemic

January 28, 2022 / 12:13 IST
Story continues below Advertisement
Dr Angelique Coetzee is the South African doctor who flagged the Omicron variant. (Illustration: Suneesh Kalarickal)

Dr Angelique Coetzee, the South African doctor who first alerted authorities to the Omicron variant of the coronavirus, doesn’t see the pandemic ending soon, dashing hopes that the fast-spreading strain could induce herd immunity.

The 62-year-old private practitioner based in Pretoria, who is also the chair of the South African Medical Association, says new variants will most probably keep emerging in the foreseeable future and we will not come out of the pandemic easily.

Story continues below Advertisement

In an email interview to Moneycontrol, she talks about the Omicron variant, how it differs from the Delta strain and why antibiotics don’t help. Edited excerpts:

Is there any data on the time gap for reinfection by the Omicron variant among those vaccinated? Can a person who has been infected get the Covid in a short time? 

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show